171 related articles for article (PubMed ID: 37816037)
1. Designing peptides predicted to bind to the omicron variant better than ACE2 via computational protein design and molecular dynamics.
Sitthiyotha T; Treewattanawong W; Chunsrivirot S
PLoS One; 2023; 18(10):e0292589. PubMed ID: 37816037
[TBL] [Abstract][Full Text] [Related]
2. Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor.
Sitthiyotha T; Chunsrivirot S
Sci Rep; 2021 Aug; 11(1):15650. PubMed ID: 34341401
[TBL] [Abstract][Full Text] [Related]
3. Computational Design of 25-mer Peptide Binders of SARS-CoV-2.
Sitthiyotha T; Chunsrivirot S
J Phys Chem B; 2020 Dec; 124(48):10930-10942. PubMed ID: 33200935
[TBL] [Abstract][Full Text] [Related]
4. Computational Design and Experimental Validation of ACE2-Derived Peptides as SARS-CoV-2 Receptor Binding Domain Inhibitors.
Sarma S; Herrera SM; Xiao X; Hudalla GA; Hall CK
J Phys Chem B; 2022 Oct; 126(41):8129-8139. PubMed ID: 36219223
[TBL] [Abstract][Full Text] [Related]
5. Computational redesign of Beta-27 Fab with substantially better predicted binding affinity to the SARS-CoV-2 Omicron variant than human ACE2 receptor.
Treewattanawong W; Sitthiyotha T; Chunsrivirot S
Sci Rep; 2023 Sep; 13(1):15476. PubMed ID: 37726329
[TBL] [Abstract][Full Text] [Related]
6. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2.
Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT
J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain.
Pitsillou E; Liang JJ; Beh RC; Hung A; Karagiannis TC
Comput Biol Med; 2022 Oct; 149():106035. PubMed ID: 36055162
[TBL] [Abstract][Full Text] [Related]
8. Computational redesign of Fab CC12.3 with substantially better predicted binding affinity to SARS-CoV-2 than human ACE2 receptor.
Treewattanawong W; Sitthiyotha T; Chunsrivirot S
Sci Rep; 2021 Nov; 11(1):22202. PubMed ID: 34772947
[TBL] [Abstract][Full Text] [Related]
9. Oxalic acid blocked the binding of spike protein from SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variants to human angiotensin-converting enzymes 2.
Wang M; Yan H; Chen L; Wang Y; Li L; Zhang H; Miao L
PLoS One; 2023; 18(5):e0285722. PubMed ID: 37200310
[TBL] [Abstract][Full Text] [Related]
10. Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein.
Pei P; Qin H; Chen J; Wang F; He C; He S; Hong B; Liu K; Qiao R; Fan H; Tong Y; Chen L; Luo SZ
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34180984
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies.
Samanta A; Alam SSM; Ali S; Hoque M
Funct Integr Genomics; 2023 Jan; 23(1):36. PubMed ID: 36631570
[TBL] [Abstract][Full Text] [Related]
12. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants.
da Costa CHS; de Freitas CAB; Alves CN; Lameira J
Sci Rep; 2022 May; 12(1):8540. PubMed ID: 35595778
[TBL] [Abstract][Full Text] [Related]
13. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
Lata S; Akif M
J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
[TBL] [Abstract][Full Text] [Related]
14. Probing the binding nature and stability of highly transmissible mutated variant alpha to omicron of SARS-CoV-2 RBD with ACE2 via molecular dynamics simulation.
Ramakrishnan J; Chinnamadhu A; Suresh S; Poomani K
J Cell Biochem; 2023 Aug; 124(8):1115-1134. PubMed ID: 37435893
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody.
Omotuyi O; Olubiyi O; Nash O; Afolabi E; Oyinloye B; Fatumo S; Femi-Oyewo M; Bogoro S
Comput Biol Med; 2022 Mar; 142():105226. PubMed ID: 35066447
[TBL] [Abstract][Full Text] [Related]
16. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
17. Atomistic insights into the binding of SARS-CoV-2 spike receptor binding domain with the human ACE2 receptor: The importance of residue 493.
Carter C; Airas J; Parish CA
J Mol Graph Model; 2023 Jan; 118():108360. PubMed ID: 36401897
[TBL] [Abstract][Full Text] [Related]
18. Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2.
Golcuk M; Yildiz A; Gur M
J Mol Graph Model; 2022 Dec; 117():108286. PubMed ID: 35964366
[TBL] [Abstract][Full Text] [Related]
19. Computational analysis of affinity dynamics between the variants of SARS-CoV-2 spike protein (RBD) and human ACE-2 receptor.
Sultana N; Nagesha SN; Reddy CNL; Ramesh BN; Shyamalamma S; Shashidhara KS; Satish KM; Pradeep C; Vidyadhar GD
Virol J; 2024 Apr; 21(1):88. PubMed ID: 38641844
[TBL] [Abstract][Full Text] [Related]
20. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.
Lupala CS; Ye Y; Chen H; Su XD; Liu H
Biochem Biophys Res Commun; 2022 Jan; 590():34-41. PubMed ID: 34968782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
